Table of Content

Chapter 1 Introduction
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Research Methodology
Information Sources
Geographic Breakdown
Segmentation Breakdown

Chapter 2 Summary and Highlights
Market Outlook
Market Summary

Chapter 3 Market Overview
Definitions of Adult Obesity and Overweight
Overweight- and Obesity-Related Diseases
Rising Prevalence of Obesity
Impact of Obesity on Global Economy
Increasing Awareness Regarding Obesity
SWOT Analysis
Strengths
Weaknesses
Opportunities
Threats

Chapter 4 Global Market for Anti-obesity Drugs by Type
Prescription Drugs
Over-the-Counter Anti-obesity Drugs

Chapter 5 Global Market for Anti-obesity Drugs by Distribution Channel
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies

Chapter 6 Global Market for Anti-obesity Drugs by Region
North America
Europe
Asia-Pacific
Rest of the World

Chapter 7 ESG Developments
Introduction to ESG
Importance of ESG in Anti-obesity Drugs Industry
ESG Pillars in the Anti-obesity Drug Industry
Environmental Metrics
Social Metrics
Governance Metrics
ESG Ratings and Metrics: Understanding the Data
ESG Practices in the Anti-obesity Drug Industry
Environmental Performance
Social Performance
Governance Performance

Chapter 8 Competitive Landscape
Overview
Pipeline Analysis
Patents on Obesity Management, 2020-2023

Chapter 9 Company Profiles
ALTIMMUNE INC.
BOEHRINGER INGELHEIM INTERNATIONAL GMBH
CURRAX PHARMACEUTICALS LLC
ELI LILLY AND CO.
F. HOFFMANN-LA ROCHE AG
GLAXOSMITHKLINE PLC
NOVO NORDISK A/S
PFIZER INC.
RHYTHM PHARMACEUTICALS, INC.
VIVUS LLC



List of Figures


Summary Figure : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021–2028
Figure 1 : Global Market for Anti-obesity Drugs: SWOT Analysis
Figure 2 : Global Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 3 : Global Market for Anti-obesity Prescription Drugs, by Region, 2021-2028
Figure 4 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, 2021-2028
Figure 5 : Global Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 6 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, 2021-2028
Figure 7 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, 2021-2028
Figure 8 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, 2021-2028
Figure 9 : Global Market Shares of Anti-obesity Drugs, by Region, 2023
Figure 10 : North American Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 11 : North American Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 12 : European Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 13 : European Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 14 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 15 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028
Figure 16 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, 2021-2028
Figure 17 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, 2021-2028

List of Tables


Summary Table : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 1 : Definitions of Adult Obesity and Overweight
Table 2 : Number of People, Aged Over 5 Years, and Percentage of the Population With Overweight or Obesity, 2020-2035
Table 3 : Global Obesity Trends for Children and Adolescents, Aged 5 to 19 Years, by Gender, 2020-2035
Table 4 : Global Obesity Trends for Adults, Aged 20 Years and Above, by Gender, 2020-2035
Table 5 : Global Economic Impact of High BMI (BMI ?25kg/m?), 2020-2035
Table 6 : Global Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 7 : Difference between Prescription Drugs and Over-the-Counter Anti-obesity Drugs
Table 8 : Approved Prescription Drugs to Treat Overweight and Obesity
Table 9 : Global Market for Anti-obesity Prescription Drugs, by Region, Through 2028
Table 10 : Global Market for Over-the-Counter Anti-obesity Drugs, by Region, Through 2028
Table 11 : Global Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 12 : Global Market for Anti-obesity Drugs Sold through Hospital Pharmacies, by Region, Through 2028
Table 13 : Global Market for Anti-obesity Drugs Sold through Retail Pharmacies, by Region, Through 2028
Table 14 : Global Market for Anti-obesity Drugs Sold through Online Pharmacies, by Region, Through 2028
Table 15 : Global Market for Anti-obesity Drugs, by Region, Through 2028
Table 16 : North American Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 17 : North American Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 18 : European Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 19 : European Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 20 : Asia-Pacific Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 21 : Asia-Pacific Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 22 : Rest of the World Market for Anti-obesity Drugs, by Drug Type, Through 2028
Table 23 : Rest of the World Market for Anti-obesity Drugs, by Distribution Channel, Through 2028
Table 24 : ESG Ratings and Metrics
Table 25 : Environmental Performance
Table 26 : Social Performance
Table 27 : Governance Performance
Table 28 : ESG Rankings for Major Anti-obesity Drug Companies, 2023*
Table 29 : Anti-obesity Drugs in Clinical Trials, 2023
Table 30 : Patents on Obesity Management, 2020-2023
Table 31 : Altimmune: Pipeline Products
Table 32 : Altimmune: News, 2023
Table 33 : Boehringer Ingelheim: Pipeline Products
Table 34 : Boehringer Ingelheim: News, 2023
Table 35 : Currax Pharmaceuticals LLC: Products
Table 36 : Currax Pharmaceuticals LLC: News, 2022
Table 37 : Eli Lilly: Pipeline Products
Table 38 : Eli Lilly: News, 2023
Table 39 : ROCHE: Products
Table 40 : GlaxoSmithKline: Products
Table 41 : Novo Nordisk A/S: Products
Table 42 : Novo Nordisk A/S: Pipeline Products
Table 43 : Novo Nordisk A/S: News, 2023
Table 44 : Pfizer: Pipeline Products
Table 45 : Pfizer: News, 2023
Table 46 : Rhythm Pharmaceuticals: Products
Table 47 : Rhythm Pharmaceuticals: Pipeline Products
Table 48 : Rhythm Pharmaceuticals: News, 2023
Table 49 : VIVUS LLC: Products
Table 50 : VIVUS LLC: News, 2023